semaglutide approval mash ๐Exciting news that is now FDA approved for (aka fatty liver disease) โAt week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Scientific Poster: Resmetirom and Semaglutide
Description
Compounded Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss: the Direct-to-Consumer Market in Colorado
Patients typically regained approximately two thirds of the weight they had lost within a year of stopping using the medication (1,3)
3 Cryo-EM data processing and validation
Muscle loss also affects strength, mobility, bone density, and overall health outcomes
For you personally, the sensible move is simple
"Single-dose oral azithromycin prophylaxis in planned vaginal delivery for sepsis prevention: A systematic review and meta-analysis of randomized controlled trials"
